BENJAMIN F. EDWARDS & COMPANY, INC. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
BENJAMIN F. EDWARDS & COMPANY, INC. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11
+37.5%
5,5410.0%0.00%
Q2 2023$8
-57.9%
5,541
-39.3%
0.00%
-100.0%
Q1 2023$19
-51.3%
9,136
-73.5%
0.00%
-50.0%
Q4 2022$39
-99.9%
34,412
+78.7%
0.00%0.0%
Q3 2022$31,000
+24.0%
19,2550.0%0.00%
+100.0%
Q2 2022$25,000
-44.4%
19,255
-30.8%
0.00%
-50.0%
Q1 2022$45,000
-26.2%
27,836
-6.0%
0.00%
-33.3%
Q4 2021$61,000
-33.7%
29,615
+25.5%
0.00%
-40.0%
Q3 2021$92,000
-17.1%
23,600
-32.0%
0.01%
-16.7%
Q2 2021$111,000
+382.6%
34,693
+224.2%
0.01%
+500.0%
Q1 2021$23,000
+4.5%
10,700
+10.3%
0.00%0.0%
Q4 2020$22,000
-15.4%
9,7000.0%0.00%
-50.0%
Q3 2020$26,000
+420.0%
9,700
+546.7%
0.00%
Q2 2020$5,000
+66.7%
1,5000.0%0.00%
Q1 2020$3,000
-25.0%
1,5000.0%0.00%
Q4 2019$4,000
-33.3%
1,5000.0%0.00%
Q3 2019$6,0000.0%1,5000.0%0.00%
-100.0%
Q2 2019$6,000
-25.0%
1,5000.0%0.00%0.0%
Q1 2019$8,000
+60.0%
1,5000.0%0.00%0.0%
Q4 2018$5,0001,5000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$222,0000.08%
Geneos Wealth Management Inc. 478,067$626,0000.03%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$16,0000.01%
Atria Wealth Solutions, Inc. 281,700$369,0000.01%
Vivaldi Capital Management LP 17,078$22,0000.01%
OSAIC HOLDINGS, INC. 1,284,481$1,684,0000.00%
Ameritas Advisory Services, LLC 45,302$59,0000.00%
CENTAURUS FINANCIAL, INC. 20,947$27,0000.00%
Summit Trail Advisors, LLC 23,855$31,0000.00%
WEDBUSH SECURITIES INC 27,998$37,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders